| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $11.18M | -2,034 | |
| VP | 109.2K | $5.42M | - | |
| VP | 69.4K | $3.44M | -9,000 | |
| Dir | 43.3K | $2.15M | -44,472 | |
| CFO | 36.7K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 5,000 | $30.00 | $150,005.00 | -7.5% | +17.5% | - | |
| Jan 2, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 4,000 | $28.00 | $112,000.00 | -6.1% | +23.3% | - | |
| Dec 3, 2025 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 3,748 | $30.00 | $112,447.12 | -5.4% | -1.1% | - | |
| Dec 1, 2025 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 4,000 | $29.30 | $117,200.00 | -5.7% | +4.6% | - | |
| Nov 3, 2025 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $30.38 | $273,441.60 | -11.4% | +15.9% | - | |
| Oct 15, 2025 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $31.53 | $283,776.30 | -10.9% | -9.6% | - | |
| Jun 10, 2025 | Nichols Christian Todd48 | SVP, Chief Commercial Officer | Sell | 6,667 | $31.52 | $210,143.41 | -3.7% | -8.4% | +41.1% | |
| Feb 28, 2025 | Parisi Samuel Joseph62 | VP, Finance (interim Pao) | Sale+OE | 1,938 | $34.00 | $65,892.00 | -20.1% | -11.9% | -12.3% | |
| Feb 25, 2025 | Parisi Samuel Joseph62 | VP, Finance (interim Pao) | Sale+OE | 3,743 | $35.26 | $131,978.18 | -32.7% | -14.4% | -11.2% | |
| Feb 20, 2025 | Parisi Samuel Joseph62 | VP, Finance (interim Pao) | Sale+OE | 1,327 | $35.69 | $47,360.63 | -14.7% | -14.0% | -10.1% |